EUVIMEDEUVIMED entdecken
Crossref

Clinical Impact of PillCam Crohn's Capsule Endoscopy in Inflammatory Bowel Disease Management

J. Goncalves, A. I. Ferreira, T. Lima Capela, J. Magalhães, B. Rosa, J. Cotter

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S302

DOI: 10.1055/s-0044-1783419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von J. Goncalves und 5 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

PillCam Crohn's Capsule (PCC) enables comprehensive examination of the entire gastrointestinal tract, offering high diagnostic yield for small bowel and colonic inflammation in Crohn's disease (CD) patients. Despite its potential, limited research has focused on the clinical implications of PCC in routine clinical practice. This study aimed to investigate the clinical impact of PCC in the management of inflammatory bowel disease (IBD) patients.

Methods

PCC procedures conducted as part of IBD investigations were retrospectively selected and patient clinical records were analyzed.

Results

A total of 72 PCC systematic procedures were included, of these patients 62.5% were females with a mean age of 42±15 years. The clinical indication for the procedure was suspected CD in 52 (72.2%) patients, 18 (25%) for CD reevaluation, and 2 (2.8%) for Ulcerative Colitis assessment. We observed a rate of 77.8% complete examinations. PCC procedures directly influenced management decisions in 34 (47.2%) of patients. Specifically, in suspected CD cases, PCC altered the management in 27 patients (51.9%), favoring CD diagnosis in 7 (25.9%), and revealing other conditions in 20 (74.1%). In those patients submitted to PCC for CD staging, the procedure prompted management changes in 38.9% of patients (n=7). Among these, six patients underwent therapeutic step-up, while one patient's diagnosis was revised to irritable bowel syndrome. [ 1 ]

Conclusions

Our study demonstrates the substantial clinical impact of non-invasive PillCam Crohn's capsule endoscopy in the management of IBD patients. PCC not only aids in the accurate diagnosis, staging and therapeutic management of CD but also plays a crucial role in identifying alternative conditions. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Goncalves, J., Ferreira, A. I., Capela, T. L., Magalhães, J., Rosa, B., & Cotter, J. (2024). Clinical Impact of PillCam Crohn's Capsule Endoscopy in Inflammatory Bowel Disease Management. Endoscopy, 56(S 02 S 02), S302. https://doi.org/10.1055/s-0044-1783419

Vancouver

Goncalves J, Ferreira AI, Capela TL, Magalhães J, Rosa B, Cotter J. Clinical Impact of PillCam Crohn's Capsule Endoscopy in Inflammatory Bowel Disease Management. Endoscopy. 2024;56(S 02 S 02):S302. doi:10.1055/s-0044-1783419

BibTeX
@article{Goncalves2024,
  author = {Goncalves, J. and Ferreira, A. I. and Capela, T. Lima and Magalhães, J. and Rosa, B. and Cotter, J.},
  title = {Clinical Impact of PillCam Crohn's Capsule Endoscopy in Inflammatory Bowel Disease Management},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S302},
  doi = {10.1055/s-0044-1783419}
}
Kostenlos starten →